Authors:
Cumming, GP
Narayansingh, GV
Parkin, DE
Haites, N
Citation: Gp. Cumming et al., Sequential occurrence within three years in a premenopausal woman of cervical, ovarian, and endometrial cancers - Drug induced long QT syndrome., POSTG MED J, 77(907), 2001, pp. 344
Authors:
Stewart, K
Wilson, P
Wilson, H
Minto, A
Haites, N
Whiting, P
Macleod, A
Brown, P
Citation: K. Stewart et al., Thy1 glomerulonephritis induced in young Lewis rats accelerates age-related glomerulosclerosis, NEPHRON, 88(1), 2001, pp. 57-64
Authors:
Stewart, GS
Last, JIK
Stankovic, T
Haites, N
Kidd, AMJ
Byrd, PJ
Taylor, AMR
Citation: Gs. Stewart et al., Residual ataxia telangiectasia mutated protein function in cells from ataxia telangiectasia patients, with 5762ins137 and 7271T -> G mutations, showing a less severe phenotype, J BIOL CHEM, 276(32), 2001, pp. 30133-30141
Authors:
Lakhani, SR
Gusterson, BA
Jacquemier, J
Sloane, JP
Anderson, TJ
van de Vijver, MJ
Venter, D
Freeman, A
Antoniou, A
McGuffog, L
Smyth, E
Steel, CM
Haites, N
Scott, RJ
Goldgar, D
Neuhausen, S
Daly, PA
Ormiston, W
McManus, R
Scherneck, S
Ponder, BAJ
Futreal, PA
Peto, J
Stoppa-Lyonnet, D
Bignon, YJ
Struewing, JP
Bishop, DT
Klijn, JGM
Devilee, P
Cornelisse, CJ
Lasset, C
Lenoir, G
Barkardottir, RB
Egilsson, V
Hamann, U
Chang-Claude, J
Sobol, H
Weber, B
Easton, DF
Stratton, MR
Citation: Sr. Lakhani et al., The pathology of familial breast cancer: Histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2, CLIN CANC R, 6(3), 2000, pp. 782-789
Authors:
Donaghy, M
Sisodiya, SM
Kennett, R
McDonald, B
Haites, N
Bell, C
Citation: M. Donaghy et al., Steroid responsive polyneuropathy in a family with a novel myelin protein zero mutation, J NE NE PSY, 69(6), 2000, pp. 799-805
Citation: E. Nelis et al., Mutations in the peripheral myelin genes and associated genes in inheritedperipheral neuropathies, HUM MUTAT, 13(1), 1999, pp. 11-28
Authors:
Miedzybrodzka, Z
Hattersley, AT
Ellard, S
Pearson, D
de Silva, D
Harvey, R
Haites, N
Citation: Z. Miedzybrodzka et al., Non-penetrance in a MODY 3 family with a mutation in the hepatic nuclear factor 1 alpha gene: implications for predictive testing, EUR J HUM G, 7(6), 1999, pp. 729-732
Authors:
Hodgson, S
Milner, B
Brown, I
Bevilacqua, G
Chang-Claude, J
Eccles, D
Evans, G
Gregory, H
Moller, P
Morrison, P
Steel, M
Stoppa-Lyonnet, D
Vasen, H
Haites, N
Citation: S. Hodgson et al., Cancer genetics services in Europe, DIS MARKER, 15(1-3), 1999, pp. 3-13
Authors:
Chang-Claude, J
Becher, H
Caligo, M
Eccles, D
Evans, G
Haites, N
Hodgson, S
Moller, P
Weber, BHF
Stoppa-Lyonnet, D
Citation: J. Chang-claude et al., Risk estimation as a decision-making tool for genetic analysis of the breast cancer susceptibility genes, DIS MARKER, 15(1-3), 1999, pp. 53-65
Authors:
Steel, M
Smyth, E
Vasen, H
Eccles, D
Evans, G
Moller, P
Hodgson, S
Stoppa-Lyonnet, D
Chang-Claude, J
Caligo, M
Morrison, P
Haites, N
Citation: M. Steel et al., Ethical, social and economic issues in familial breast cancer: a compilation of views from the EC biomed II demonstration project, DIS MARKER, 15(1-3), 1999, pp. 125-131
Authors:
Evans, DGR
Anderson, E
Lalloo, F
Vasen, H
Beckmann, M
Eccles, D
Hodgson, S
Moller, P
Chang-Claude, J
Morrison, P
Stoppa-Lyonnet, D
Steel, M
Haites, N
Citation: Dgr. Evans et al., Utilisation of prophylactic mastectomy in 10 European centers, DIS MARKER, 15(1-3), 1999, pp. 148-151
Authors:
Miedzybrodzka, Z
Hamilton, NM
Gregory, H
Milner, B
Frade, I
Sinclair, T
Mollison, J
Haites, N
Citation: Z. Miedzybrodzka et al., Teaching breast cancer genetics to medical students: Evaluation of a computer assister learning (CAL) package, DIS MARKER, 15(1-3), 1999, pp. 157-157
Authors:
Moller, P
Reis, MM
Evans, G
Vasen, H
Haites, N
Anderson, E
Steel, CM
Apold, J
Lalloo, F
Maehle, L
Preece, P
Gregory, H
Heimdal, K
Citation: P. Moller et al., Efficacy of early diagnosis and treatment in women with a family history of breast cancer, DIS MARKER, 15(1-3), 1999, pp. 179-186
Citation: H. Gregory et al., Audit of women attending the Aberdeen Genetic Clinic with a family historyof breast cancer who subsequently develop cancer, DIS MARKER, 15(1-3), 1999, pp. 201-203
Authors:
Moller, P
Evans, G
Haites, N
Vasen, H
Reis, MM
Anderson, E
Apold, J
Hodgson, S
Eccles, D
Olsson, H
Stoppa-Lyonnet, D
Chang-Claude, J
Morrison, PJ
Bevilacqua, G
Heimdal, K
Maehle, L
Lalloo, F
Gregory, H
Preece, P
Borg, A
Nevin, NC
Caligo, M
Steel, CM
Citation: P. Moller et al., Guidelines for follow-up of women at high risk for inherited breast cancer: Consensus statement from the Biomed 2 Demonstration Programme on Inherited Breast Cancer, DIS MARKER, 15(1-3), 1999, pp. 207-211
Authors:
Burn, J
Alonso, A
Bertario, L
Bishop, T
Bisgaard, ML
Cummings, J
Davidson, R
Delhanty, J
Demant, P
Dunlop, M
Eccles, D
Ellis, A
Evans, G
Fidalgo, P
Fodde, R
Haites, N
Hodgson, S
Hultcrantz, R
Huson, S
Jarvinen, H
Kartheuser, A
Kleibeuker, J
Lenaerts, C
Lucasson, A
Lunt, P
McDermot, K
McKay, J
McKeown, C
Maher, E
Mathers, J
Mecklin, JP
Moslein, G
Murday, V
Nagengast, F
Northover, JMA
Obrador, A
Parks, TG
Paraskeva, C
Phillips, R
San Roman, C
Ruscheoff, J
Sampson, J
Shepherd, N
Tempesta, A
Trembath, R
Turnpenny, P
Vasen, HFA
Citation: J. Burn et al., Concerted action polyp prevention, CAPP2: A trial of aspirin and/or resistant starch in people at risk of hereditary non-polyposis colon cancer (HNPCC), BIOM HLTH R, 24, 1998, pp. 17-23